8.3KTreatment Views
39Answers
6.3KViews of Answers
When medication Fails to kick in Wears off unexpectedly Is required more frequently Gives intolerable side effects When symptoms Become unresponsive to medication Interfere with daily activities Reduces the quality of life
This is again a very common question for people who are considering DBS, and if you are selected, we pick the participants very carefully. Usually, we achieve a very high success rate, meaning that they feel it is a very great help to them and they will even recommend it to their friends with Parkinson's disease. I think in terms of failure, taking in mind the complications we expect, there is a risk of serious complication about 1% and a risk of infection about 3%.
Ended on June 19, 2020
After completing medical school, Dr Nicolas Kon continued his medical training in neurosurgery and neurocritical care at various institutes in the UK which include the National Hospital for Neurology and Neurosurgery (London), Charing Cross Hospital (London), Addenbrooke’s Hospital (Cambridge) as well as the National Neuroscience Institute (NNI) in Singapore. He obtained his PhD at Imperial College London and subsequently completed his fellowship at Toronto Western Hospital, University of Toronto in Canada. Before practising at Mount Elizabeth Hospital. Currently, he is an Adj Associate Professor at the Yong Loo Lin School of Medicine, NUS. He is actively involved in several clinical and translational research and multi-centre international trials. In addition, he holds several patents for his discoveries. He has authored more than 80 peer-reviewed publications and serves on the Centralised Institutional Review Board. Dr Kon is the first neurosurgeon to use the Brainpath minimally invasive neurosurgical technique in Asia. He has a longstanding commitment to neurosurgery and has received a long service award from the National Neuroscience Institute, Singapore for his contribution. In addition, Dr Kon also has a strong passion towards patient care and has been awarded several Service with A Heart awards by the SGH.
Ended on July 18, 2020
After completing medical school, Dr Nicolas Kon continued his medical training in neurosurgery and neurocritical care at various institutes in the UK which include the National Hospital for Neurology and Neurosurgery (London), Charing Cross Hospital (London), Addenbrooke’s Hospital (Cambridge) as well as the National Neuroscience Institute (NNI) in Singapore. He obtained his PhD at Imperial College London and subsequently completed his fellowship at Toronto Western Hospital, University of Toronto in Canada. Before practising at Mount Elizabeth Hospital. Currently, he is an Adj Associate Professor at the Yong Loo Lin School of Medicine, NUS. He is actively involved in several clinical and translational research and multi-centre international trials. In addition, he holds several patents for his discoveries. He has authored more than 80 peer-reviewed publications and serves on the Centralised Institutional Review Board. Dr Kon is the first neurosurgeon to use the Brainpath minimally invasive neurosurgical technique in Asia. He has a longstanding commitment to neurosurgery and has received a long service award from the National Neuroscience Institute, Singapore for his contribution. In addition, Dr Kon also has a strong passion towards patient care and has been awarded several Service with A Heart awards by the SGH.